Litigation over the Biomet hip replacements has resolved in a global settlement. The result is a plan for several-hundred plaintiffs to receive a base award of $200,000 for each hip they have had ...

Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the heels of a warning from the U.S. Food and Drug Administration (FDA), ...

Please provide your email address to receive an email when new articles are posted on . Zimmer Biomet Holdings Inc. has announced the acquisition of Ossis. Ossis is a medical device company that ...

On Wednesday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates. The orthopedic giant reported sales of ...

WARSAW, Ind., Sept. 1, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today announced an exclusive, multi-year co-marketing agreement with Surgical ...

iTaperloc ® Complete and iG7 ™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...

Zimmer Biomet Holdings recently announced that Japan’s Pharmaceutical and Medical Devices Agency approved the iTaperloc Complete and iG7 Hip System, featuring Iodine Technology to inhibit bacterial ...

Feb 3 (Reuters) - U.S. medical device maker Biomet Inc will pay at least $56 million to settle a multi-district lawsuit relating to defective metal hip replacements, a court filing showed, ending a ...

I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet’s recent achievement in receiving Japan's Pharmaceutical and Medical Devices Agency (PMDA) approval for orthopedic ...

Zimmer Biomet Holdings, Inc. ZBH recently inked an exclusive, multi-year co-marketing agreement with Surgical Planning Associates, Inc. to commercialize the FDA-approved HipInsight mixed reality ...

Total knee replacement surgery just got a bit of an IQ boost. The FDA offered up a de novo clearance for Zimmer Biomet and Canary Medical’s Persona IQ system, marking it as the first “smart” knee ...